Across TCGA pan-cancer cohorts, KIAA1671 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated KIAA1671 data layer compared with 20 for mass-spec protein and 3 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher KIAA1671 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated KIAA1671 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC and LIHC are the cancer types where KIAA1671 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	0.935	0.622	.007	16	view →
LIHC	DFS	Median	All	0.130	0.545	.005	12	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: KIAA1671 tumor-vs-normal RNA expression · all KIAA1671 data types